PortfoliosLab logo

Akebia Therapeutics, Inc. (AKBA)

Equity · Currency in USD · Last updated Mar 27, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in Akebia Therapeutics, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $239 for a total return of roughly -97.61%. All prices are adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%100.00%NovemberDecember2023FebruaryMarch
-97.61%
112.12%
AKBA (Akebia Therapeutics, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with AKBA

Akebia Therapeutics, Inc.

Return

Akebia Therapeutics, Inc. had a return of 10.75% year-to-date (YTD) and -74.13% in the last 12 months. Over the past 10 years, Akebia Therapeutics, Inc. had an annualized return of -33.93%, while the S&P 500 had an annualized return of 8.71%, indicating that Akebia Therapeutics, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
1 month-2.29%-0.66%
Year-To-Date10.75%3.42%
6 months92.47%5.67%
1 year-74.13%-10.89%
5 years (annualized)-42.88%8.95%
10 years (annualized)-33.93%8.71%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20239.19%33.81%
2022-13.19%-19.30%6.27%112.92%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Akebia Therapeutics, Inc. Sharpe ratio is -0.59. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.90-0.80-0.70-0.60-0.50-0.40-0.30-0.20NovemberDecember2023FebruaryMarch
-0.59
-0.47
AKBA (Akebia Therapeutics, Inc.)
Benchmark (^GSPC)

Dividend History


Akebia Therapeutics, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%NovemberDecember2023FebruaryMarch
-97.81%
-17.21%
AKBA (Akebia Therapeutics, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Akebia Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Akebia Therapeutics, Inc. is 99.14%, recorded on Nov 17, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.14%Jun 23, 20142119Nov 17, 2022
-36.84%Mar 21, 201416Apr 11, 20145Apr 21, 201421
-21.82%Apr 22, 201420May 19, 201414Jun 9, 201434
-4.91%Jun 10, 20146Jun 17, 20143Jun 20, 20149

Volatility Chart

Current Akebia Therapeutics, Inc. volatility is 107.98%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%250.00%NovemberDecember2023FebruaryMarch
107.98%
19.50%
AKBA (Akebia Therapeutics, Inc.)
Benchmark (^GSPC)